Acute Endophthalmitis Caused by Leuconostoc spp. following Intravitreal Bevacizumab Injection

We present a case of acute endophthalmitis caused by Leuconostoc spp. following intravitreal bevacizumab injection. An 86-year-old immunocompetent female developed acute endophthalmitis after intravitreal injection of bevacizumab for neovascular age-related macular degeneration. The patient presente...

Full description

Bibliographic Details
Main Authors: Supreet Singh, Chirag V. Patel, Kamal Kishore
Format: Article
Language:English
Published: Karger Publishers 2017-10-01
Series:Case Reports in Ophthalmology
Subjects:
Online Access:https://www.karger.com/Article/FullText/480727
_version_ 1818964786019303424
author Supreet Singh
Chirag V. Patel
Kamal Kishore
author_facet Supreet Singh
Chirag V. Patel
Kamal Kishore
author_sort Supreet Singh
collection DOAJ
description We present a case of acute endophthalmitis caused by Leuconostoc spp. following intravitreal bevacizumab injection. An 86-year-old immunocompetent female developed acute endophthalmitis after intravitreal injection of bevacizumab for neovascular age-related macular degeneration. The patient presented with pain, visual acuity of hand motions, hypopyon, and dense vitritis 96 h after treatment. She was treated with vitreous and anterior chamber tap followed by intravitreal injections of 1 mg vancomycin, 2.25 mg ceftazidime, and 400 μg dexamethasone. Cultures revealed growth of Leuconostoc spp., a genus of gram-positive bacteria that is inherently resistant to vancomycin. Due to persistent inflammation, pars plana vitrectomy (PPV) with intravitreal injection of 0.4 mg amikacin was performed 16 days later, followed by resolution of endophthalmitis and return of vision to 20/40. In conclusion, the management of acute endophthalmitis caused by Leuconostoc spp., a gram-positive coccobacillus, can be particularly challenging due to its inherent resistance to vancomycin. PPV with intravitreal amikacin led to resolution of endophthalmitis. Our case expands the number of cases of endophthalmitis caused by Leuconostoc spp. and highlights the possibility of Leuconostoc-related endophthalmitis in an outpatient setting in an immunocompetent host.
first_indexed 2024-12-20T13:06:38Z
format Article
id doaj.art-af6d186ad99f4746884d4af43a2347d8
institution Directory Open Access Journal
issn 1663-2699
language English
last_indexed 2024-12-20T13:06:38Z
publishDate 2017-10-01
publisher Karger Publishers
record_format Article
series Case Reports in Ophthalmology
spelling doaj.art-af6d186ad99f4746884d4af43a2347d82022-12-21T19:39:46ZengKarger PublishersCase Reports in Ophthalmology1663-26992017-10-018351051410.1159/000480727480727Acute Endophthalmitis Caused by Leuconostoc spp. following Intravitreal Bevacizumab InjectionSupreet SinghChirag V. PatelKamal KishoreWe present a case of acute endophthalmitis caused by Leuconostoc spp. following intravitreal bevacizumab injection. An 86-year-old immunocompetent female developed acute endophthalmitis after intravitreal injection of bevacizumab for neovascular age-related macular degeneration. The patient presented with pain, visual acuity of hand motions, hypopyon, and dense vitritis 96 h after treatment. She was treated with vitreous and anterior chamber tap followed by intravitreal injections of 1 mg vancomycin, 2.25 mg ceftazidime, and 400 μg dexamethasone. Cultures revealed growth of Leuconostoc spp., a genus of gram-positive bacteria that is inherently resistant to vancomycin. Due to persistent inflammation, pars plana vitrectomy (PPV) with intravitreal injection of 0.4 mg amikacin was performed 16 days later, followed by resolution of endophthalmitis and return of vision to 20/40. In conclusion, the management of acute endophthalmitis caused by Leuconostoc spp., a gram-positive coccobacillus, can be particularly challenging due to its inherent resistance to vancomycin. PPV with intravitreal amikacin led to resolution of endophthalmitis. Our case expands the number of cases of endophthalmitis caused by Leuconostoc spp. and highlights the possibility of Leuconostoc-related endophthalmitis in an outpatient setting in an immunocompetent host.https://www.karger.com/Article/FullText/480727EndophthalmitisLeuconostocIntravitreal injectionsBevacizumab
spellingShingle Supreet Singh
Chirag V. Patel
Kamal Kishore
Acute Endophthalmitis Caused by Leuconostoc spp. following Intravitreal Bevacizumab Injection
Case Reports in Ophthalmology
Endophthalmitis
Leuconostoc
Intravitreal injections
Bevacizumab
title Acute Endophthalmitis Caused by Leuconostoc spp. following Intravitreal Bevacizumab Injection
title_full Acute Endophthalmitis Caused by Leuconostoc spp. following Intravitreal Bevacizumab Injection
title_fullStr Acute Endophthalmitis Caused by Leuconostoc spp. following Intravitreal Bevacizumab Injection
title_full_unstemmed Acute Endophthalmitis Caused by Leuconostoc spp. following Intravitreal Bevacizumab Injection
title_short Acute Endophthalmitis Caused by Leuconostoc spp. following Intravitreal Bevacizumab Injection
title_sort acute endophthalmitis caused by leuconostoc spp following intravitreal bevacizumab injection
topic Endophthalmitis
Leuconostoc
Intravitreal injections
Bevacizumab
url https://www.karger.com/Article/FullText/480727
work_keys_str_mv AT supreetsingh acuteendophthalmitiscausedbyleuconostocsppfollowingintravitrealbevacizumabinjection
AT chiragvpatel acuteendophthalmitiscausedbyleuconostocsppfollowingintravitrealbevacizumabinjection
AT kamalkishore acuteendophthalmitiscausedbyleuconostocsppfollowingintravitrealbevacizumabinjection